Cargando…

Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose

Background: The effects of various dosages and treatment regimens on intravitreal aflibercept concentrations and the proportion of free vascular endothelial growth factor (VEGF) to total VEGF were evaluated using a drug and disease assessment model. The 8 mg dosage received specific attention. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Veritti, Daniele, Sarao, Valentina, Di Bin, Francesco, Lanzetta, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220677/
https://www.ncbi.nlm.nih.gov/pubmed/37242658
http://dx.doi.org/10.3390/pharmaceutics15051416